Depreciation of Larimar Therapeutics, Inc. from 31 Dec 2012 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Larimar Therapeutics, Inc. quarterly and annual Depreciation in USD history and change rate from 31 Dec 2012 to 31 Mar 2025.
  • Larimar Therapeutics, Inc. Depreciation for the quarter ending 31 Mar 2025 was $88,000, a 10% increase year-over-year.
  • Larimar Therapeutics, Inc. annual Depreciation for 2024 was $318,000, a 2.3% increase from 2023.
  • Larimar Therapeutics, Inc. annual Depreciation for 2023 was $311,000, a 2.2% decline from 2022.
  • Larimar Therapeutics, Inc. annual Depreciation for 2022 was $318,000, a 2.5% decline from 2021.
Source SEC data
View on sec.gov
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

Larimar Therapeutics, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $88,000 +$8,000 +10% 01 Jan 2025 31 Mar 2025 10-Q 30 Apr 2025 2025 Q1
Q1 2024 $80,000 +$2,000 +2.6% 01 Jan 2024 31 Mar 2024 10-Q 30 Apr 2025 2025 Q1
Q1 2023 $78,000 -$4,000 -4.9% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q1 2022 $82,000 +$9,000 +12% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q3 2021 $100,000 01 Jul 2021 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q1 2021 $73,000 +$50,000 +217% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1
Q1 2020 $23,000 -$28,000 -55% 01 Jan 2020 31 Mar 2020 10-Q 10 May 2021 2021 Q1
Q1 2019 $51,000 +$1,000 +2% 01 Jan 2019 31 Mar 2019 10-Q 07 May 2020 2020 Q1
Q1 2018 $50,000 +$9,000 +22% 01 Jan 2018 31 Mar 2018 10-Q 09 May 2019 2019 Q1
Q1 2017 $41,000 -$9,000 -18% 01 Jan 2017 31 Mar 2017 10-Q 09 May 2017 2017 Q1
Q1 2016 $50,000 +$45,000 +900% 01 Jan 2016 31 Mar 2016 10-Q 09 May 2017 2017 Q1
Q1 2015 $5,000 +$2,000 +67% 01 Jan 2015 31 Mar 2015 10-Q 10 May 2016 2016 Q1
Q1 2014 $3,000 01 Jan 2014 31 Mar 2014 10-Q 14 May 2015 2015 Q1

Larimar Therapeutics, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $318,000 +$7,000 +2.3% 01 Jan 2024 31 Dec 2024 10-K 24 Mar 2025 2024 FY
2023 $311,000 -$7,000 -2.2% 01 Jan 2023 31 Dec 2023 10-K 24 Mar 2025 2024 FY
2022 $318,000 -$8,000 -2.5% 01 Jan 2022 31 Dec 2022 10-K 14 Mar 2024 2023 FY
2021 $326,000 +$171,000 +110% 01 Jan 2021 31 Dec 2021 10-K 14 Mar 2023 2022 FY
2020 $155,000 +$77,000 +99% 01 Jan 2020 31 Dec 2020 10-K 25 Mar 2022 2021 FY
2019 $78,000 -$183,000 -70% 01 Jan 2019 31 Dec 2019 10-K 04 Mar 2021 2020 FY
2018 $261,000 +$73,000 +39% 01 Jan 2018 31 Dec 2018 10-K 05 Mar 2020 2019 FY
2017 $188,000 -$24,000 -11% 01 Jan 2017 31 Dec 2017 10-K 05 Mar 2020 2019 FY
2016 $212,000 +$142,000 +203% 01 Jan 2016 31 Dec 2016 10-K 14 Mar 2019 2018 FY
2015 $70,000 +$54,000 +338% 01 Jan 2015 31 Dec 2015 10-K 09 Mar 2018 2017 FY
2014 $16,000 +$4,000 +33% 01 Jan 2014 31 Dec 2014 10-K 10 Mar 2017 2016 FY
2013 $12,000 +$1,000 +9.1% 01 Jan 2013 31 Dec 2013 10-K 15 Mar 2016 2015 FY
2012 $11,000 01 Jan 2012 31 Dec 2012 10-K 25 Mar 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.